Companies / Health Care / Health Care Distributors
McKesson stock buybacks
MCK$6.7Bbought back in the 12 months to Jun 30, 2026
McKesson bought back $6.7B of its stock in the last twelve months. Its share count is down 5.0% from a year earlier.
Show as table
| Period | Value |
|---|---|
| Q3 '20 | $248M |
| Q4 '20 | $252M |
| Q1 '21 | $242M |
| Q2 '21 | $1.0B |
| Q3 '21 | $264M |
| Q4 '21 | $714M |
| Q1 '22 | $1.5B |
| Q2 '22 | $1B |
| Q3 '22 | $484M |
| Q4 '22 | $2.0B |
| Q1 '23 | $138M |
| Q2 '23 | $696M |
| Q3 '23 | $809M |
| Q4 '23 | $842M |
| Q1 '24 | $678M |
| Q2 '24 | $527M |
| Q3 '24 | $1.5B |
| Q4 '24 | $827M |
| Q1 '25 | $300M |
| Q2 '25 | $581M |
| Q3 '25 | $818M |
| Q4 '25 | $680M |
| Q1 '26 | $2.7B |
| Q2 '26 | $2.5B |
Show as table
| Period | Value |
|---|---|
| Q3 '20 | 163.2M |
| Q4 '20 | 159.5M |
| Q1 '21 | 156.5M |
| Q2 '21 | 158.1M |
| Q3 '21 | 155.8M |
| Q4 '21 | 151.6M |
| Q1 '22 | 150.9M |
| Q2 '22 | 145.9M |
| Q3 '22 | 144.1M |
| Q4 '22 | 141.0M |
| Q1 '23 | 137.8M |
| Q2 '23 | 136.6M |
| Q3 '23 | 134.8M |
| Q4 '23 | 133.3M |
| Q1 '24 | 131.7M |
| Q2 '24 | 130.7M |
| Q3 '24 | 129.3M |
| Q4 '24 | 126.6M |
| Q1 '25 | 125.8M |
| Q2 '25 | 125.5M |
| Q3 '25 | 124.4M |
| Q4 '25 | 123.7M |
| Q1 '26 | 122.8M |
| Q2 '26 | 119.2M |
$2.5Blast quarter (Q2 2026)
—net of stock compensation (—)
−5.0%diluted shares, 1 year
−22.7%diluted shares, 5 years
$393Mdividends, 12 months
104%of free cash flow ($6.4B) spent on buybacks
$0raised by issuing stock, 12 months
$5.2Bleft under its authorization as of Jun 30, 2026
By fiscal year
Questions
- Does McKesson buy back its stock?
- McKesson bought back $6.7B of its stock in the last twelve months. Its share count is down 5.0% from a year earlier.
- How much did McKesson spend on buybacks in fiscal 2026?
- $4.8B, according to its 10-K for the fiscal year ending Mar 31, 2026.
- Is McKesson's share count going down?
- Its diluted share count changed −22.7% over five fiscal years and −5.0% over the last year.
- Does McKesson have a buyback authorization?
- Its filings show $5.2B remaining under its repurchase authorization as of Jun 30, 2026.
Latest filing used: 10-Q for the period ending Jun 30, 2026, filed Aug 5, 2026 · open on SEC.gov